Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,398,633
+$22,018,504 QoQ
Shares Held
1,200,239
+23.0% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#12
of 315 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $4,031,464,727 across 23 Biotechnology names. VCEL ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,920,953 | $1,947,654,982 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,859,172 | $1,159,268,108 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
580,187 | $174,653,692 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
291,805 | $92,236,641 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
239,490 | $58,619,966 | |
| 6 | VCEL |
Vericel Corp
This page
|
1,200,239 | $53,398,633 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
443,636 | $51,936,466 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
434,102 | $48,198,345 |
All Filings in VCEL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,398,633 | 1,200,239 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,380,129 | 975,447 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $38,051,946 | 1,056,705 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $31,650,574 | 1,005,738 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $43,898,962 | 1,031,703 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $47,151,247 | 1,056,729 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $55,489,080 | 1,010,546 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $43,942,957 | 1,040,070 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $48,816,319 | 1,064,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $57,549,777 | 1,106,301 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $40,649,740 | 1,141,526 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $39,475,163 | 1,177,660 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $45,625,571 | 1,214,415 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $35,935,940 | 1,225,646 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,893,194 | 983,037 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $23,351,960 | 1,006,550 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,649,437 | 820,073 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $24,978,298 | 653,540 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $26,174,035 | 666,006 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||